New treatment for cancer approved for PBS listing
Pancreatic cancer drug Abraxane will be listed on the Pharmaceutical Benefits Scheme (PBS) from November 1. The Australian Government has committed over $92 million over four years to subsidise Abraxaneon the PBS. Pancreatic cancer is highly aggressive with very few treatment options. Member for Page, Kevin Hogan said more than 1,500 patients would benefit each…